Board of Directors
Mr. Vijay Karwal
Mr. Vijay Karwal
  • Independent Director
  • Member of Audit Committee
  • Chairperson of Nomination Committee
  • Chairperson of Remuneration Committee
Back

The Age (as on Dec 31, 2023)

  • 53 Years

Education

  • Association for Investment Management & Research/CFA Institute Current holder of Chartered Financial Analyst (CFA)
  • University of Groningen, The Netherlands M.Sc. in Monetary Economics
  • University of Southampton, United Kingdom Erasmus Scholar - Department of Accounting & Management Sciences

Shares held by each director (as on Dec 31, 2023)

  • None

Experiences in the past 5 Years

  • 2021 - Present

    Independent Director, Member of Audit Committee and Chairman of Nomination Committee and Remuneration Committee, Mega Lifesciences PCL / Manufacture and distribute nutraceutical and pharmaceutical products

  • 2021 - Present

    Chief Financial Officer, Executive (Non-Independent) Director, AffaMed Therapeutics, Hong Kong / developing and commercializing transformative pharmaceutical products

  • 2021 - Present

    Operating Partner, CBC, Group, Hong Kong (formerly C-Bridge Capital) is one of the largest and most active healthcare-dedicated investment firms in Asia

  • 2018 - 2021

    Managing Director, Head of Healthcare Investment Banking, Asia ex-Japan, Nomura International, Hong Kong

Back